Xenetic Biosciences Inc (XBIO) — Capital Reinvestment Ratio
Latest as of December 2017:
0.00x
Xenetic Biosciences Inc (XBIO) has a Capital Reinvestment Ratio of 0.00x as of December 2017, meaning it reinvests 0% of its operating cash flow ($4.84 Million) in capital expenditures ($9.00K). See XBIO free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$4.84 Million
USD
Capital Expenditures
$9.00K
USD
Data as of
Dec 2017
Most recent filing
Xenetic Biosciences Inc Capital Reinvestment Ratio (2017–2017)
This chart tracks Xenetic Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Xenetic Biosciences Inc (2017–2017)
Year-by-year Capital Reinvestment Ratio for Xenetic Biosciences Inc from 2017 to 2017. For live market cap and broader valuation context, see market cap of Xenetic Biosciences Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.01x | $1.49 Million | $9.26K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow